Over-the-Counter Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Background: Optimal interventions to prevent or delay cognitive decline, mild cognitive impairment (MCI), or dementia are uncertain. Purpose: To summarize the evidence on efficacy and harms of over-the-counter (OTC) supplements to prevent or delay cognitive decline, MCI, or clinical Alzheimer-type dementia in adults with normal cognition or MCI but no dementia diagnosis. Data Sources: Multiple electronic databases from 2009 to July 2017 and bibliographies of systematic reviews. Study Selection: English-language trials of at least 6 months' duration that enrolled adults without dementia and compared cognitive outcomes with an OTC supplement versus placebo or active controls. Data Extraction: Extraction performed by a single reviewer and confirmed by a second reviewer; dual-reviewer assessment of risk of bias; consensus determination of strength of evidence. Data Synthesis: Thirty-eight trials with low to medium risk of bias compared ω-3 fatty acids, soy, ginkgo biloba, B vitamins, vitamin D plus calcium, vitamin C or β-carotene, multi-ingredient supplements, or other OTC interventions with placebo or other supplements. Few studies examined effects on clinical Alzheimer-type dementia or MCI, and those that did suggested no benefit. Daily folic acid plus vitamin B12 was associated with improvements in performance on some objectively measured memory tests that were statistically significant but of questionable clinical significance. Moderate-strength evidence showed that vitamin E had no benefit on cognition. Evidence about effects of ω-3 fatty acids, soy, ginkgo biloba, folic acid alone or with other B vitamins, β-carotene, vitamin C, vitamin D plus calcium, and multivitamins or multi-ingredient supplements was either insufficient or low-strength, suggesting that these supplements did not reduce risk for cognitive decline. Adverse events were rarely reported. Limitation: Studies had high attrition and short follow-up and used a highly variable set of cognitive outcome measures. Conclusion: Evidence is insufficient to recommend any OTC supplement for cognitive protection in adults with normal cognition or MCI. Primary Funding Source: Agency for Healthcare Research and Quality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A systematic review of the use of supplements, including vitamins C, D and E, omega-3 fatty acids and ginkgo biloba, found little to no benefit in preventing cognitive decline, MCI or Alzheimer's dementia.138”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [138]
In the citing paper
“No single food, beverage, ingredient, vitamin or supplement has been proven to prevent or cure Alzheimer's or any other dementia.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [146]
Citations
Cites
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Smith, A. D., Smith, S. M., de Jager, C. A., Whitbread, P., Johnston, C., Agacinski, G., Oulhaj, A., Bradley, K. M., Jacoby, R., & Refsum, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012244 · Cited by 813
Durga, J., van Boxtel, M. P., Schouten, E. G., Kok, F. J., Jolles, J., Katan, M. B., & Verhoef, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60109-3 · Cited by 758 · cited 1×
“8 mg) compared with placebo over 3 years (31).”
DeKosky, S. T. (2008) · JAMA · doi:10.1001/jama.2008.683 · Cited by 670
Qato, D. M., Wilder, J., Schumm, L. P., Gillet, V., & Alexander, G. C. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.8581 · Cited by 658
Ginkgo biloba for cognitive impairment and dementia
Birks, J., & Grimley Evans, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003120.pub3 · Cited by 581
Beneficial effects of docosahexaenoic acid on cognition in age‐related cognitive decline
Yurko‐Mauro, K., McCarthy, D., Rom, D., Nelson, E. B., Ryan, A. S., Blackwell, A., Salem, N., Stedman, M., & MIDAS Investigators (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.01.013 · Cited by 579 · cited 5×
“One study used only docosahexaenoic acid (DHA) (17); all others used some combination of eicosapentaenoic acid (EPA) plus DHA.”
InfluentialPreventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment
Douaud, G., Refsum, H., de Jager, C. A., Jacoby, R., E. Nichols, T., Smith, S. M., & Smith, A. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301816110 · Cited by 515
de Jager, C. A., Oulhaj, A., Jacoby, R., Refsum, H., & Smith, A. D. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2758 · Cited by 457
Research works printed but not linked: 1
- Charemboon T, 2015, J Med Assoc Thai, 98, 508
Cited by
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00269-y · Cited by 2,606
2024 Alzheimer's disease facts and figures
(2024) · Alzheimer's & Dementia · doi:10.1002/alz.13809 · Cited by 2,536
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
“A systematic review [40] of the use of supplements, including (but not limited to) C, D and E vitamins, omega-3 fatty acids, and ginkgo biloba, found little to no benefit of over-the-counter supplements in preventing cognitive decline, MCI or Alzheimer’s dementia.”
2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353
2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
2021 Alzheimer's disease facts and figures
(2021) · Alzheimer's & Dementia · doi:10.1002/alz.12328 · Cited by 2,201
2025 Alzheimer's disease facts and figures
(2025) · Alzheimer's & Dementia · doi:10.1002/alz.70235 · Cited by 474
Yu, J.-T., Xu, W., Tan, C.-C., Andrieu, S., Suckling, J., Evangelou, E., Pan, A., Zhang, C., Jia, J., Feng, L., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-321913 · Cited by 482
Mild Cognitive Impairment in Clinical Practice: A Review Article
Jongsiriyanyong, S., & Limpawattana, P. (2018) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317518791401 · Cited by 457
“Generally, existing OTC supplements have limited evidence for cognitive protection.(68)”
BackgroundDominguez, L. J., Veronese, N., Vernuccio, L., Catanese, G., Inzerillo, F., Salemi, G., & Barbagallo, M. (2021) · Nutrients · doi:10.3390/nu13114080 · Cited by 433
Management of mild cognitive impairment (MCI): The need for national and international guidelines
Kasper, S., Bancher, C., Eckert, A., Förstl, H., Frölich, L., Hort, J., Korczyn, A. D., Kressig, R. W., Levin, O., & Palomo, M. S. M. (2020) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2019.1696473 · Cited by 233
Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials
Avallone, R., Vitale, G., & Bertolotti, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174256 · Cited by 218
Promoting Successful Cognitive Aging: A Ten-Year Update
Krivanek, T. J., Gale, S. A., McFeeley, B. M., Nicastri, C. M., & Daffner, K. R. (2021) · Journal of Alzheimer’s Disease · doi:10.3233/jad-201462 · Cited by 172
“fatty acids, soy, gingko biloba, B vitamins, vitamin D plus calcium, vitamin C or beta-carotene, multiingredient supplements, and other over-the-counter interventions, and found insufficient evidence that any of these supplements improved cognitive performance in a clinically meaningful way or reduced the risk of cogn…”
BackgroundWang, Z., Zhu, W., Xing, Y., Jia, J., & Tang, Y. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuab057 · Cited by 144
Dorninger, F., Forss-Petter, S., Wimmer, I., & Berger, J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105061 · Cited by 139
Van Dael, P. (2021) · Nutrition Research and Practice · doi:10.4162/nrp.2021.15.2.137 · Cited by 138
“There is recent evidence that n-3 LCPUFA supplementation may have beneficial effects on neurodegenerative disorders [66,67], such as Parkinson's disease (PD) and Alzheimer's disease (AD) [68-71].”
BackgroundNutrition and the ageing brain: Moving towards clinical applications
Flanagan, E. C., Lamport, D. J., Brennan, L., Burnet, P. W. J., Calabrese, V., Cunnane, S. C., de Wilde, M. C., Dye, L., Farrimond, J. A., Lombardo, N. B. E., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101079 · Cited by 138
“The deterioration of brain energy metabolism is specific to glucose – it does not affect the brain’s metabolism of ketone bodies in older people (Castellano et al., 2019), in MCI (Fortier et al., 2019) or in AD itself (Croteau et al., 2018).”
InfluentialNutritional prevention of cognitive decline and dementia.
Dominguez, L. J., & Barbagallo, M. (2018) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v89i2.7401 · Cited by 166
“Similar studies suggest biological plausibility and cognitive effects of other single or multi-ingredient supplements, which recently has been judged as insufficient (14).”
BackgroundYassine, H. N., Samieri, C., Livingston, G., Glass, K., Wagner, M., Tangney, C., Plassman, B. L., Ikram, M. A., Voigt, R. M., Gu, Y., et al. (2022) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(22)00120-9 · Cited by 116
“64 Furthermore, partici pants’ baseline nutritional status was infrequently known, raising the risk that a high proportion had already sufficient nutritional status of the nutrients under study.”
Self-citationNew Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer’s Disease
Guzmán‐Martínez, L., Calfío, C., Farias, G. A., Vilches, C., Prieto, R., & Maccioni, R. B. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201059 · Cited by 120
Fišar, Z. (2022) · Biomolecules · doi:10.3390/biom12111676 · Cited by 120
Effects of cocoa extract and a multivitamin on cognitive function: a randomized clinical trial
Baker, L. D., Manson, J. E., Rapp, S. R., Sesso, H. D., Gaussoin, S. A., Shumaker, S. A., & Espeland, M. A. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12767 · Cited by 88
Mancinelli, A. C., Mattioli, S., Twining, C. W., Bosco, A. D., Donoghue, A. M., Arsi, K., Angelucci, E., Chiattelli, D., & Castellini, C. (2022) · Nutrients · doi:10.3390/nu14091969 · Cited by 106
Cattaneo, G., Bartrés‐Faz, D., Morris, T. P., Sánchez, J. S., Macià, D., Tarrero, C., Tormos, J. M., & Pascual‐Leone, Á. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00321 · Cited by 95
“Several recent reviews and meta-analyses have demonstrated the weaknesses and inconsistencies of single physical, nutritional, or cognitive interventions (Brasure et al., 2018; Butler et al., 2018a,b) for the promotion of cognitive fitness and brain health.”
BackgroundDaimiel, L., Martínez‐González, M. Á., Corella, D., Salas‐Salvadó, J., Schröder, H., Vioqué, J., Romaguera, D., Martínez, J. A., Wärnberǵ, J., López‐Miranda, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-59458-6 · Cited by 80
Brainard, J. S., Jimoh, O. F., Deane, K. H. O., Biswas, P., Donaldson, D., Maas, K., Abdelhamid, A. S., Hooper, L., Ajabnoor, S., Alabdulghafoor, F., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.02.022 · Cited by 68
Demoret, R. M., Baker, M. A., Ohtawa, M., Chen, S., Lam, C. C., Khom, S., Roberto, M., Forli, S., Houk, K. N., & Shenvi, R. A. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c08231 · Cited by 74
Fadzil, N. H. M., Shahar, S., Rajikan, R., Singh, D. K. A., Ludin, A. F. M., Subramaniam, P., Ibrahim, N., Vanoh, D., Ali, N. M., & Noah, S. A. M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19074000 · Cited by 71
Low, D. Y., Lefèvre‐Arbogast, S., González‐Domínguez, R., Urpí-Sardà, M., Micheau, P., Pétéra, M., Centeno, D., Durand, S., Pujos‐Guillot, E., Kőrösi, A., et al. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900177 · Cited by 65
Prevention of Cognitive Decline in Alzheimer’s Disease by Novel Antioxidative Supplements
Tadokoro, K., Ohta, Y., Inufusa, H., Loon, A. F. N., & Abe, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061974 · Cited by 60
Mild Cognitive Impairment: An Overview
Bhattarai, B., & Nagaraj, H. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106192 · Cited by 57
CoQ10 and Mitochondrial Dysfunction in Alzheimer’s Disease
Fišar, Z., & Hroudová, J. (2024) · Antioxidants · doi:10.3390/antiox13020191 · Cited by 68
“These supplements, such as CoQ 10 , ω -3 fatty acids, soy, ginkgo biloba, B vitamins, vitamin D plus calcium, vitamin C, and β -carotene have not yet been shown to prevent cognitive dysfunction in AD [128,139].”
BackgroundWalia, V., Kaushik, D., Mittal, V., Kumar, K., Verma, R., Parashar, J., Akter, R., Rahman, M. H., Bhatia, S., Al-Harrasi, A., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02617-1 · Cited by 47
“Further, the findings from the AD patients suggested that they often have some nutritional deficiency due to the impaired availability of those nutrients [358].”
BackgroundVyas, C. M., Manson, J. E., Sesso, H. D., Cook, N. R., Rist, P. M., Weinberg, A., Moorthy, M. V., Baker, L. D., Espeland, M. A., Yeung, L., et al. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.12.011 · Cited by 58
Personalized nutrition for dementia prevention
Samieri, C., Yassine, H. N., van Lent, D. M., Lefèvre‐Arbogast, S., van de Rest, O., Bowman, G. L., & Scarmeas, N. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12486 · Cited by 53
Chen, S.-J., Huang, G., Yuan, L.-Q., Zeng, Q., Wang, D., Wen, X.-Y., Shi, Y., & Zhu, F. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.295345 · Cited by 53
“Furthermore, over-the-counter medicines have not been found to supplement cognitive protection in adults with MCI (Butler et al., 2018a).”
BackgroundA Public Health Issue: Dietary Supplements Promoted for Brain Health and Cognitive Performance
Crawford, C., Boyd, C., Avula, B., Wang, Y.-H., Khan, I. A., & Deuster, P. A. (2020) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2019.0447 · Cited by 43
Non-Enzymatic Antioxidants against Alzheimer’s Disease: Prevention, Diagnosis and Therapy
Varesi, A., Campagnoli, L. I. M., Carrara, A., Pola, I., Floris, E., Ricevuti, G., Chirumbolo, S., & Pascale, A. (2023) · Antioxidants · doi:10.3390/antiox12010180 · Cited by 53
Nutrition to Prevent or Treat Cognitive Impairment in Older Adults: A GRADE Recommendation
Buckinx, F., & Aubertin‐Leheudre, M. (2021) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2020.40 · Cited by 45
“A greater consumption of vitamin D (18-21) 1C”
BackgroundInfluential2026 Alzheimer's disease facts and figures
(2026) · Alzheimer s & Dementia · doi:10.1002/alz.71345 · Cited by 112
Ashley, S., Bradburn, S., & Murgatroyd, C. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1681066 · Cited by 43
Manser, P., & de Bruin, E. D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.734012 · Cited by 41
Polyunsaturated fatty acids and risk of Alzheimer’s disease: a Mendelian randomization study
Tomata, Y., Larsson, S. C., & Hägg, S. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02126-x · Cited by 38
Tsoukalas, D., Zlatian, O., Mitroi, M., Renieri, E., Tsatsakis, A., Izotov, B. N., Burada, F., Sosoi, S., Burada, E., Buga, A. M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040624 · Cited by 36
Tadokoro, K., Morihara, R., Ohta, Y., Hishikawa, N., Kawano, S., Sasaki, R., Matsumoto, N., Nomura, E., Nakano, Y., Takahashi, Y., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190644 · Cited by 35
“However, systematic reviews concluded that a single supplement such as vitamin B[20-22], vitamin C[20, 22],”
InfluentialGhassab‐Abdollahi, N., Mobasseri, K., Ahmadabad, A. D., Nadrian, H., & Mirghafourvand, M. (2021) · Phytotherapy Research · doi:10.1002/ptr.7126 · Cited by 38
“…acid alone or with other B vitamins, ß-carotene, vitamin C, vitamin D plus calcium, and multivitamins or multi-ingredient supplements had no benefit on the reduction of risk for cognitive decline but daily folic acid plus vitamin B12 illustrated improvements in memory scores (Butler et al., 2018).”
BackgroundWoon, C. K., Hui, W. K., Abas, R., Haron, M. H., Das, S., & Lin, T. S. (2021) · Current Neuropharmacology · doi:10.2174/1570159x20666211217163540 · Cited by 37
Nutrition for dementia prevention: a state of the art update for clinicians
Townsend, R. F., McGrattan, A., Gregory, S., Ritchie, C. W., Stevenson, E., & Shannon, O. M. (2024) · Age and Ageing · doi:10.1093/ageing/afae030 · Cited by 35
Andrews, V., Zammit, G., & O’Leary, F. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad013 · Cited by 33
Association Between Serum Vitamins and the Risk of Alzheimer’s Disease in Chinese Population
Liu, X., Wu, P.-F., Liu, Y., Jiang, Y., Wan, M., Xiao, X., Yang, Q., Jiao, B., Liao, X., Wang, J., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215104 · Cited by 29
Toepfer, S., Bolbrinker, J., König, M., Steinhagen‐Thiessen, E., Kreutz, R. H., & Demuth, I. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226511 · Cited by 26
“Ginkgo biloba extracts (N = 23) are traditionally used as over-the-counter (OTC) supplements to prevent or delay cognitive decline, even though evidence for this effect is insufficient [34].”
Evaluation of the effect of aroma oil as a bath salt on cognitive function
Kouzuki, M., Kitao, S., Kaju, T., & Urakami, K. (2019) · Psychogeriatrics · doi:10.1111/psyg.12481 · Cited by 28
Dong, L., Hyde, A. J., Zhang, A. L., Xue, C. C., & May, B. H. (2019) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2018.0346 · Cited by 30
“10 In recent years, herbs and dietary supplements have received considerable research attention for MCI and associated disorders 11–13 and there is evidence that exercise may improve cognitive function in MCI.”
Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer’s Disease
Flieger, J., Forma, A., Flieger, W., Flieger, M., Gawlik, P. J., Dzierżyński, E., Maciejewski, R., Teresiński, G., & Baj, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168982 · Cited by 37
“The benefits of using β -carotene as a supplement in the prevention of AD are also controversial, as shown by a systematic review of the literature [266].”
MethodJung, S., Jung, E., Ha, K.-C., Baek, H.-I., Park, Y., Han, S.-K., Chae, S., Lee, S., & Chung, Y. (2021) · Nutrients · doi:10.3390/nu13082606 · Cited by 30
“A recent study investigating natural and synthetic over-the-counter supplements in MCI and AD patients [11] reported the ineffectiveness ofω-3 fatty acids, soy, ginkgo biloba, folic acid, vitamins B, and antioxidative nutrient in protecting MCI and AD.”
BackgroundMasuoka, N., Lei, C., Li, H., Inamura, N., Shiotani, S., Yanai, N., Sato, K., Sakurai, K., & Hisatsune, T. (2021) · Aging · doi:10.18632/aging.202535 · Cited by 26
“The pursuit of drug targets other than the inhibition of senile plaques accumulation or neurodegeneration would be hoped [11].”
BackgroundChang, J., Liu, M., Liu, C., Zhou, S., Jiao, Y., Sun, H., & Ji, Y. (2024) · European Journal of Nutrition · doi:10.1007/s00394-024-03324-y · Cited by 28
Lefèvre‐Arbogast, S., Wagner, M., Proust‐Lima, C., & Samieri, C. (2019) · Current Nutrition Reports · doi:10.1007/s13668-019-00285-1 · Cited by 23
Zhou, J., Ma, L., Zhao, L., Sheng, J., Xu, Y., Chen, J., Yu, L., Sun, Q., Zhou, H., Zhu, S., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210141 · Cited by 22
Current Advances in Mitochondrial Targeted Interventions in Alzheimer’s Disease
de Sousa, T. S., Moreira, P. I., & Cardoso, S. (2023) · Biomedicines · doi:10.3390/biomedicines11092331 · Cited by 24
“Beyond these novel mitochondrial-directed antioxidative supplements, considerable pre-clinical evidence exists demonstrating the beneficial effects of conventional antioxidants like vitamins C and E [197] and carotenoids (for a review, see [198]) on AD-related pathology.”
Kang, Y. K., Lee, B. Y., Bucci, L. R., & Stohs, S. J. (2018) · Nutrients · doi:10.3390/nu10020233 · Cited by 22
A Multifactor Approach to Mild Cognitive Impairment
Qarni, T., & Salardini, A. (2019) · Seminars in Neurology · doi:10.1055/s-0039-1678585 · Cited by 23
Wang, Z.-T., Fu, Y., Zhang, Y.-R., Chen, S.-D., Huang, S., Liu, Y., Li, H., Ou, Y., Feng, J., Dong, Q., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02269-2 · Cited by 21
Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease
Villegas, C., Perez, R., Petiz, L. L., Glaser, T., Ulrich, H., & Paz, C. (2022) · IUBMB Life · doi:10.1002/iub.2613 · Cited by 20
An appraisal of folates as key factors in cognition and ageing-related diseases
Craenen, K., Verslegers, M., Baatout, S., & Benotmane, M. A. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1549017 · Cited by 22
“…also addressed in a recent review, pointing out the lack of clinical significance, insufficient follow-up and undesirably high variation in cognitive measurements in adults at risk for cognitive decline which were given so-called ‘over-the-counter’ supplements containing FA (Butler et al. 2018).”
BackgroundPrevention of Late-Life Dementia: No Magic Bullet
Larson, E. B. (2017) · Annals of Internal Medicine · doi:10.7326/m17-3026 · Cited by 18
Baltic, S., Nedeljkovic, D., Todorović, N., Ranisavljev, M., Korovljev, D., Cvejić, J., Ostojic, J. N., LeBaron, T. W., Timmcke, J. Q., Štajer, V., et al. (2024) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2024.100287 · Cited by 21
Tao, M., Liu, H., Cheng, J., Yu, C., & Zhao, L. (2023) · Behavioral Sciences · doi:10.3390/bs13090737 · Cited by 19
“The medical field currently prefers to promote non-pharmacological therapies to avoid causing adverse drug reactions in patients [7,8].”
Homocysteine: A modifiable culprit of cognitive impairment for us to conquer?
Ji, Y., Lyu, P., Jin, W., Li, X., Li, X., & Dong, Y. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.07.015 · Cited by 21
Crawford, C. C., Boyd, C. C., & Deuster, P. A. (2021) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2021.0135 · Cited by 19
Prevention of late-life dementia: what works and what does not
Tipton, P. W., & Graff‐Radford, N. R. (2018) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.4263 · Cited by 20
Haley, A. P., Oleson, S., Pasha, E. P., Birdsill, A. C., Kaur, S., Thompson, J., & Tanaka, H. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13673 · Cited by 14
Tong, J., Gao, J., Liu, Q., He, C.-Y., Zhao, X., Qi, Y., Yuan, T., Li, P., Niu, M., Wang, D., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104618 · Cited by 14
Manser, P., Michels, L., Schmidt, A., Barinka, F., & de Bruin, E. D. (2023) · JMIR Research Protocols · doi:10.2196/41173 · Cited by 17
“…antihypertensive, anti-inflammatory, or lipid-lowering medication, or hormone therapies) and nutritional supplements is largely insufficient and does not support their use for improving cognitive performance, slowing down cognitive decline, or reducing the risk of developing dementia [41-46].”
Association between having a family member with dementia and perceptions of dementia preventability
Lee, W., Gray, S. L., Zaslavsky, O., Barthold, D., & Marcum, Z. A. (2020) · Aging & Mental Health · doi:10.1080/13607863.2020.1839866 · Cited by 13
Diagnosis of Alzheimer's disease: Towards accuracy and accessibility
Mu, Y., Chang, K., Chen, Y.-F., Yan, K., Wang, C.-X., & Hua, Q. (2024) · Journal of Biological Methods · doi:10.14440/jbm.2024.412 · Cited by 14
“Additionally, it is still being investigated whether changes of daily dietary habits contribute to a reduction in the incidence of AD [6-7].”
BackgroundGalluzzi, S., Marizzoni, M., Gatti, E., Bonfiglio, N. S., Cattaneo, A., Epifano, F., Frisoni, G. B., Genovese, S., Geviti, A., Marchetti, L., et al. (2024) · Nutrition Journal · doi:10.1186/s12937-024-01039-8 · Cited by 13
“The use of over-the-counter supplements to boost memory is rapidly increasing among older adults [12, 13].”
BackgroundGuo, H., Tian, Q., Qin, X., Luo, Q., Gong, X., & Gao, Q. (2024) · Nutritional Neuroscience · doi:10.1080/1028415x.2024.2342164 · Cited by 14
“Similar studies have shown that various single-or multi-ingredient supplements fall short in terms of scientific explanation and impact on cognition [3,11–13].”
Weiner‐Light, S., Tomasino, F., Wescott, A., Sideman, A. B., VELA, A. M., Possin, K. L., Penedo, F. J., & Wolf, M. S. (2023) · Aging & Mental Health · doi:10.1080/13607863.2023.2268050 · Cited by 14
“Importantly, a systematic review found little to no benefit from the use of supplements or vitamins in preventing cognitive decline or ADRD (Butler et al., 2018); therefore, although this belief will likely result in little benefit, the misperception may additionally represent vulnerability to…”
BackgroundJean, K. R., & Dotson, V. M. (2024) · Neurologic Clinics · doi:10.1016/j.ncl.2024.05.005 · Cited by 12
Suzuki, Y., Sakakibara, M., Shiraishi, N., Komiya, H., Akishita, M., & Kuzuya, M. (2020) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000512043 · Cited by 10
Dong, Y., Huang, T., Zhai, Z., Dong, Q., Xia, Z., Xia, Z., Yu, J., Jiang, X., Hong, K., Wu, Y., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.995838 · Cited by 8
Evaluation of Dietary Intake in Individuals with Mild Cognitive Impairment
Nien, S.-W., Lin, I.-H., Wu, H.-C., Chen, Y.-H., & Yang, S. (2023) · Nutrients · doi:10.3390/nu15173694 · Cited by 10
Vitamin D intake and cognitive decline in Blacks and Whites: The role of diet and supplements
Dhana, K., Barnes, L. L., Agarwal, P., Liu, X., Dhana, A., Desai, P., Aggarwal, N. T., Evans, D. A., & Rajan, K. B. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12729 · Cited by 9
Kim, Y. J., Kim, Y., Kim, J., Kim, Y. H., Yoon, D. Y., & Bae, J. S. (2020) · BioMed Research International · doi:10.1155/2020/1836471 · Cited by 8
Li, Y., Yan, Z., Shao, N., Tang, S. H., Zhang, X., Liu, X. M., & Tang, J. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2024.07.023 · Cited by 8
Stoehr, G. P., Jacobsen, E. P., Jia, Y., Snitz, B. E., & Ganguli, M. (2019) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000357 · Cited by 7
Alzheimers's disease: Epidemiological characteristics and its prevention
Grujičić, J., & Nikolić, A. (2021) · Zdravstvena zastita · doi:10.5937/zdravzast50-32931 · Cited by 8
Eat for better cognition in older adults at risk for Alzheimer's disease
Wang, Y., Niu, X., & Peng, D. (2023) · Nutrition · doi:10.1016/j.nut.2022.111969 · Cited by 7
Cuervo-Zanatta, D., Pérez-Grijalva, B., González-Magaña, E., Hernández-Acosta, J., Murugesan, S., García-Mena, J., & Perez‐Cruz, C. (2021) · Studies in natural products chemistry · doi:10.1016/b978-0-12-819489-8.00019-3 · Cited by 8
Kim, S., Shin, H., Baek, J., Park, J. Y., Kim, M., Hahm, S., & Cho, H.-Y. (2024) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.70012 · Cited by 8
Bioactive compounds and dietary patterns in Alzheimer's disease
Christimann, G., dos Santos, G. R., & Sattler, J. A. G. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251319048 · Cited by 8
“74 Healthy individuals were given a mixture of lutein, zeaxanthin, and meso-zeaxanthin for a year, aiming to reach macular levels.”
CNN-SVM for prediction Alzheimer disease in early step
Rabeh, A. B., Benzarti, F., & Amiri, H. (2023) · International Conference on Control, Automation and Diagnosis (ICCAD) · doi:10.1109/iccad57653.2023.10152440 · Cited by 9
“To achieve this, it will naturally and progressively develop adaptability [16, 17].”
BackgroundGorelick, P. B. (2020) · Springer eBooks · doi:10.1007/978-3-030-49586-2_6 · Cited by 7
Beliefs about benefits and harms of medications and supplements for brain health
Marcum, Z. A., Hohl, S. D., Barthold, D., Zaslavsky, O., Larson, E. B., & Gray, S. L. (2020) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2020.101060 · Cited by 7
“However, two recent evidence-based reviews of findings from 89 randomized controlled trials reported that evidence is insufficient to support the use of certain medications and supplements for cognitive protection in persons with normal cognition or mild cognitive impairment (Butler et al., 2018; Fink et al, 2018).”
BackgroundInfluentialClinically studied or clinically proven? Memory for claims in print advertisements
Murphy, D. H., Schwartz, S. T., Alberts, K. O., Siegel, A. L. M., Carone, B. J., Castel, A. D., & Drolet, A. L. (2023) · Applied Cognitive Psychology · doi:10.1002/acp.4106 · Cited by 7
AI-Enabled Conversational Agents in Service of Mild Cognitive Impairment Patients
Kostis, I.-A., Karamitsios, K., Kotrotsios, K., Tsolaki, M., & Tsolaki, A. (2022) · International Conference on Electrical and Information Technology (IEIT) · doi:10.1109/ieit56384.2022.9967865 · Cited by 5
“As of today, there is no medically verified cure or method of prevention for any of the known dementia types[7], [8], [9], [10].”
MethodLifestyle medicine for healthy cognitive aging: A narrative review
Halma, M. T. J., Marik, P. E., Gazda, S., & Tuszyński, J. A. (2024) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2024.100077 · Cited by 6
Randolph, J. J., Lacritz, L. H., Colvin, M. K., Espe‐Pfeifer, P., Carter, K. R., Arnett, P. A., Fox‐Fuller, J. T., Aduen, P. A., Cullum, C. M., & Sperling, S. A. (2023) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acad078 · Cited by 4
Metadata
- Authors
- Butler, M., Nelson, V. A., Davila, H., Ratner, E., Fink, H. A., Hemmy, L. S., McCarten, J. R., Barclay, T. R., Brasure, M., & Kane, R. L.
- Affiliations
- University of Minnesota (US)
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2018-01-02
- Volume
- 168
- Issue
- 1
- Pages
- 52-62
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2778293650
- Cited by
- 144
- References
- 52
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 17 · 2023: 16 · 2022: 17 · 2021: 25 · 2020: 20 · 2019: 21 · 2018: 11
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- over-the-counter supplements, cognitive decline, mild cognitive impairment, Alzheimer-type dementia, dementia prevention, omega-3 fatty acids, soybean, Ginkgo biloba, B vitamins, folic acid, vitamin B12, vitamin E, beta-carotene, vitamin C, multivitamins, memory, adverse events
- MeSH terms
- Alzheimer Disease, Nonprescription Drugs, Humans, Dietary Supplements, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.